Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation
Open Access
- 10 July 2023
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 29 (9) , 581.e1-581.e8
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Recent Advances in the Biology of the Urothelium and Applications for Urinary Bladder DysfunctionBioMed Research International, 2014
- The polyomavirus puzzle: is host immune response beneficial in controlling BK virus after adult hematopoietic cell transplantion?Transplant Infectious Disease, 2014
- Population pharmacokinetics of dimethylacetamide in children during standard and once-daily IV busulfan administrationCancer Chemotherapy and Pharmacology, 2013
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor typeHaematologica, 2010
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideTransplantation and Cellular Therapy, 2008
- A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factorBlood, 2008
- Hemorrhagic cystitis: a retrospective single‐center surveyClinical Transplantation, 2007
- The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicityBone Marrow Transplantation, 2000
- Microsomal metabolism of N,N-diethylacetamide and N,N-dimethylacetamide and their effects on drug-metabolizing enzymes of rat liverBiochemical Pharmacology, 1994